018737132

ABDERA THERAPEUTICS

---

July 21, 2022

Trademark Summary

The trademark application ABDERA THERAPEUTICS was filed by Abdera Therapeutics Inc, a corporation established under the laws of Canada (the "Applicant"). Application under examination.

The application was filed in Danish (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer
  2. Pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer
  3. Pharmaceutical preparations for the treatment of cancer
  4. Radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer
  5. Pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer
  6. Pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer
  7. Diagnostic imaging agents for use in diagnosing cancer
  8. Medicines
  9. Pharmaceutical and veterinary preparations
  10. Chemical, analytical and diagnostic reagents for in vivo use
  11. Chemicals for use in medical research, and medical or veterinary diagnosis
  12. Pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders
  13. Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders
  14. Pharmaceutical preparations for the treatment of metabolic diseases and disorders
  15. Pharmaceutical products for the prevention and treatment of cancer, cardiovascular diseases and genetic disorders
  16. Pharmaceutical and medical preparations and substances
  17. Drug delivery agents
  18. Drug delivery compounds that facilitate the delivery of pharmaceutical products
  19. Drug delivery agents in the form of films that facilitate the delivery of pharmaceutical products
  20. Drug delivery agents in the form of tablet coatings that facilitate the delivery of pharmaceutical products.
• The mark was filed in class 10 with following description of goods:
  
  1. Medical kits comprised of single and multi-dose vials and syringes to administer pharmaceutical products used for the treatment, prevention, and diagnosis of cancer
  2. Surgical, medical, therapeutic, dental and veterinary apparatus and instruments
  3. Drug delivery devices
  4. Devices used to deliver drugs, drug delivery solutions and suspensions, genes, polymers and biologics to the body
  5. Diagnostic apparatus for medical purposes
  6. Dispensing devices for the prolonged release of active agents
  7. Inhalers for medical purposes
  8. Parts, fittings and accessories for all the aforesaid goods.
• The mark was filed in class 42 with following description of goods:
  
  1. Pharmaceutical drug development services, namely, drug development for the treatment of cancer
  2. Research and development of pharmaceutical products using radiotherapy to target and treat tumors and cancer
  3. Scientific, medical and industrial research and development services
  4. Clinical research
  5. Laboratory research
  6. Research and development of new drugs and clinical products
  7. Analysis of materials
  8. Chemical analysis
  9. Laboratory services
  10. Laboratory testing services
  11. Medical laboratory services
  12. Information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the Internet
  13. Research and development services for pharmaceuticals and for the treatment of diseases and injuries
  14. Genetic engineering services
  15. Genetic research
  16. Scientific and technological services and research and development relating thereto
  17. Genetic testing for scientific research purposes
  18. Medical and pharmacological research services
  19. Research and development in the fields of biotechnology, biopharmaceuticals and gene therapy
  20. Clinical trials
  21. Research and development of pharmaceutical preparations
  22. Development of technological platforms services for nanoparticles manufacturing.